Tetra signs a letter of intent (LOI) with AES Environment Group
Tetra Engages in Innovative Air Analysis and Development of Specific Air Cleaning Devices with AES Environment for the Commercialization of PPP001 and for Marijuana Consumer Market
OTTAWA, ONTARIO–(Marketwired – Sept. 28, 2017) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), today announced that it has signed a letter of intent (LOI) with AES Environment Group to develop and commercialize specific products ensuring the safety of caregivers for patients who will use PPP001 or medical cannabis.
AES Environment has expertise in in situ air testing analysis of all kinds of contaminants and development of high level air cleaners for professional and institutional purposes. They design and manufacture effective filtration devices to answer specific needs of professionals in different areas. In the context of a clinical trial with both on site and at home use of PPP001, it is imperative for Tetra to control the quality of the environment of its users and ensure that caregivers, healthcare professionals (HCP) and family members, will not be affected by second hand smoke when patients are inhaling PPP001 or medical cannabis.
Tetra is being proactive in addressing the concerns of physicians and Health Canada regarding potential effects of second hand smoke. It is for this reason that Tetra is partnering with AES Environment who will provide devices that will allow healthcare professionals to safely work alongside patients smoking prescribed medical cannabis. AES Environment will provide masks specifically designed to filter tetrahydrocannabinol (THC), aldehydes and terpenes found in cannabis, allowing caregivers to work alongside patients while they are smoking. These masks can be used for all medical or interventional personnel needing to respond to an emergency situation in a closed environment where there are potentially hazardous levels of THC in the air.
As well, the Companies have signed a letter of intent to set up a partnership for the development and distribution of a specialized air purification device for both residential and professional work environments, ensuring quality of the environment during inhalation of Tetra’s smokable product PPP001. Both Companies are working together to develop a new type of portable air filter that will be used by patients inhaling medical cannabis or Tetra`s prescription drug PPP001. These filters will capture THC, aldehydes and terpene molecules, thereby preventing the exposure of HCP’s and caregivers to hazardous levels of these molecules.
Guy Godin, CEO of AES Environnement stated “I am pleased to work with an innovative company such as Tetra to be able to follow its research and adapt to the needs and standards of an ever-changing industry. This innovative filtration apparatus follows on from research that culminates with the manufacture of an air purifier dedicated to the users of this new analgesic. The device is equipped with a unique filter that absorbs all unwanted airborne particles. This filtration device also eradicates odors and ensures optimal indoor air quality, in accordance with Health Canada’s requests and recommendations”.
In parallel, Tetra and AES Environment will be conducting an extensive on-site testing of air quality, to ensure the efficacy of their devices and to provide data currently lacking, to the healthcare community. All sampling methods developed by AES Environment and Tetra will comply with the standards and regulations of the Research Institute on Health and Safety at Work Quebec (IRSST) and the Regulations on Health and Safety at Work, as well as with Health Canada requirements.
This unique data set will be collected and added to Tetra’s New Drug Submission for PPP001. The Company is confident that these will be well received by Health Canada as they provide data on air quality that currently doesn’t exist and initiate an innovative process to ensure the safety of caregivers.
Bernard Fortier, CEO of Tetra Bio-Pharma noted that “We are very fortunate to be able to work with a leader in the field of environment safety like AES Environment. What is even more exciting is that Tetra is in a position to protect our future patients’ family members, their caregivers as well as any healthcare professional involved in the care of these patients. We understand that bringing a smokable THC medication brings a responsibility to minimize the risks associated with this highly effective delivery method. From a commercial standpoint, we are working closely with our partner AES Environment in bringing a product that we can register with Health Canada as a medical device. This would potentially enable patients to reduce their out-of-pocket expenses as certain types of medical devices can be covered under private and public insurance plans. And for Tetra, this becomes another opportunity to generate a significant stream of revenue within our PPP-001 portfolio”.
With the development of its PPP001 program, Tetra has been building a solid foundation to discover and develop cannabinoid-based drugs that will address unmet medical needs of patients, while ensuring the safety and well-being of those patients who will be enrolled in the clinical trial, as well as their caregivers. With the development of these new devices, Tetra will help protect the patients’ immediate family, their caregivers and HCP workers from second-hand smoke and cannabis’ side effects.
Finally, Tetra is announcing a change to its board of directors. M. André Audet, former Chairman of the Board and one of the original founders of the company, is leaving the Board of Directors effective today. The Company wants to thank Mr Audet for his hard work and dedication in the development of Tetra; he has played a key role in the company’s growth to date. Tetra’s CEO, Mr. Bernard Fortier, will replace Mr Audet.
About AES:
AES Environment’s reputation was first built in the field of indoor air sampling and analysis, and then expanded with the creation of high-performance decontamination products for commercial and military markets. By creating this unique air purifier, the company is expanding its range of services and expertise in a field that is constantly renewing itself.
http://www.aesenvironnement.com/en/
About Tetra Bio-Pharma:
Tetra Bio-Pharma (TSX VENTURE:TBP)(OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and clinical development. Tetra has three core expertise: clinical research, pharmaceutical promotion and retail commercialization of cannabinoid-based drugs.
More information at: www.tetrabiopharma.com.
Source: Tetra Bio-Pharma
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
- Published in Tetra Bio Pharma
Relevium, Salavenia to develop products for pets
Relevium Creates Alliance With Salavenia Nutrition and Biodevas Laboratoires to Develop an Exclusive Line of Phyto and Nutraceuticals for Pets
MONTREAL, QUEBEC–(Marketwired – Sept. 28, 2017) –Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the “Company” or “Relevium”) is pleased to announce the launch of a joint cooperation with Salvenia Nutrition and Biodevas Laboratoires to develop an exclusive brand and product line of nutraceuticals and phytoceuticals targeted to Pet Care owners on a direct to consumer basis. Product and market development initiatives are expected to begin in October of this year with the objective of a preliminary launch by Spring of 2018 as a wholly-owned subsidiary of Relevium.
Relevium has retained Salvenia Nutrition (“Salvenia”), a Montreal based pet and livestock nutrition company, to lead the market research and the product line formulation process, which will consist of nutraceutical and phytoceutical based products. In addition to their long-standing expertise, Salvenia Nutrition is also an exclusive North American distributor of Biodevas Laboratoires, a leading manufacturer of veterinary Phytoceutical products based in France. Such exclusivity will be extended to Relevium’s newly developed product line for e-commerce for an initial 18-month period from the first product launch date, which is expected by spring of 2018.
Salvenia Nutrition with the assistance of a local nutraceutical formulation lab will develop new products in conjunction with the existing products currently available from the Biodevas Laboratoires.
Further updates will be issued as they become available.
Aurelio Useche, CEO of Relevium Technologies stated, “Much like their owners, pets can also suffer from nutritional deficiencies related to poor dietary intake. Keeping pets healthy and stronger requires nutritional supplements, a market that is estimated to be north of 16 billion in North America alone. We look forward to leveraging the expertise of Salvenia and Biodevas Laboratoires to develop a high quality product line to fill a real need in this market.”
About Relevium Technologies
Relevium is a TSXV listed company focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness sector. Relevium Technologies Inc. also holds patented intellectual property for the use of static magnetic fields for application on wearable devices.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
- Published in Business, Financial Technology, Life Sciences, Relevium Technologies
Sirona Subsidiary, TFChem, Receives Final Loan Tranche from French Public Investment Bank for Anti-Aging Project
Momentum Public Relations
Press Release: September 27, 2017
VANCOUVER, BC–(Marketwired – September 27, 2017) – Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) (XETRA: ZSB), (the “Company”) announced that its wholly-owned French subsidiary, TFChem, has received the final tranche of the CDN$1.2 million from Bpifrance (the French Public Investment Bank) and the district of Haute Normandie. The final loan tranche, totaling CDN$487,000, will be used to advance the organization’s anti-aging project.
Repayment of the loan will be made in installments, beginning in Q3 2018 with the majority being paid after 2020. The company expects to be well into substantial milestone and royalty payments before any repayment of the loan begins.
According to the latest report by Zion Market Research, the global anti-aging market is expected to reach USD 216.52 billion in 2021 and is anticipated to grow at a CAGR of 7.5{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} between 2016 and 2021.
“The final loan tranche will be used to further the studies for anti-aging activity and mechanism of action of the glycoprotein library compounds,” reports Dr. Howard Verrico, CEO and Chairman of Sirona Biochem, “We would like to extend our gratitude to Bpifrance and the district of Haute Normandie.”
About Sirona’s Cell Preservation / Anti-Aging Project
TFChem has developed a library of novel glycopeptides with a unique ability to protect skin fibroblasts from severe stressors that arise from the natural aging process and the environment. Studies have shown that cells coated in these glycopeptides, even when exposed to oxidation, starvation and UV irradiation, maintain vitality under the stressors.
While the compounds have undergone several rounds of testing for activity, they require further assessment to determine a mechanism of action. The library is also being evaluated for effectiveness in preserving other cell types, expanding market opportunity. Potential commercial opportunities could include cell storage, transplant and healing.
About Sirona Biochem Corp.
Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential.
Sirona’s compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona’s laboratory, TFChem, is located in France and is the recipient of multiple French national scientific awards and European Union and French government grants. For more information, please visit www.sironabiochem.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Sirona Biochem cautions you that statements included in this press release that are not a description of historical facts may be forward-looking statements. Forward-looking statements are only predictions based upon current expectations and involve known and unknown risks and uncertainties. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of release of the relevant information, unless explicitly stated otherwise. Actual results, performance or achievement could differ materially from those expressed in, or implied by, Sirona Biochem’s forward-looking statements due to the risks and uncertainties inherent in Sirona Biochem’s business including, without limitation, statements about: the progress and timing of its clinical trials; difficulties or delays in development, testing, obtaining regulatory approval, producing and marketing its products; unexpected adverse side effects or inadequate therapeutic efficacy of its products that could delay or prevent product development or commercialization; the scope and validity of patent protection for its products; competition from other pharmaceutical or biotechnology companies; and its ability to obtain additional financing to support its operations. Sirona Biochem does not assume any obligation to update any forward-looking statements except as required by law.
For more information regarding this press release, contact:
Christopher Hopton
CFO
Sirona Biochem Corp.
Phone: 1.604.282.6064
Email: chopton@sironabiochem.com
- Published in Bio technology, Life Sciences, News Home, Sirona Biochem, Technology
Defiance Announces $1.45M First Tranche of Private Placement Closed
Momentum Public Relations
Press Release: September 25, 2017
Vancouver, British Columbia–(Newsfile Corp. – September 25, 2017) – Defiance Silver Corp. (TSXV: DEF) (OTC: DNCVF) (“Defiance”) is pleased to announce that it has closed the first tranche of its private placement in the amount of $1,458,000 and issued 4,860,001 Units at a price of $0.30 per Unit. These Units are subject to a four month hold period expiring January 20, 2018. Defiance management and directors have subscribed for a total of 310,000 Units.
The proceeds of the private placement will be used by Defiance to commence a drill program at the San Acacio Silver Deposit located in Zacatecas, Mexico as well as for working capital purposes.
Each Unit consists of one common share and one common share purchase warrant. Each warrant will entitle the holder thereof to acquire one additional common share of Defiance for a period of twenty-four (24) months at an exercise price of $0.45. Finder’s fees of $112,920 and 376,400 finders’ warrants were paid in connection with the first tranche of the private placement. Each finder’s warrant entitles the holder to acquire one common share of Defiance at $.45 for 24 months.
A Panoramic Video on the San Acacio Deposit (https://www.youtube.com/watch?v=DEqtbHzMeYw) is available on our website, or Click Here to visit our Defiance YouTube Channel (http://www.defiancesilver.com/media/video). Defiance Silver Corp. is a silver explorer and developer advancing the San Acacio Deposit, located in the historic Zacatecas Silver District of central Mexico. Defiance is managed by a team of proven mine developers with a track record of exploring and developing seven operating mines to date. Defiance’s corporate mandate is to expand San Acacio to become one of Mexico’s premier high grade wide vein silver deposits.
On behalf of Defiance Silver Corp.
“Roy Bonnell“
President & CEO
For more information, please contact: Sunny Pannu – Corporate Development (604) 669 7315 or via email at pannu@defiancesilver.com
2300 – 1177 West Hastings Street
Vancouver, BC V6E 2K3
www.defiancesilver.com
Tel: 604-669-7315 Email:info@defiancesilver.com
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
- Published in Defiance Silver, Mining, News Home
Arctic Star Samples up to 0.96 from Carbonatite Discovery at the CAP Property, BC
Momentum Public Relations
Press Release: September 25, 2017
Vancouver, British Columbia–(Newsfile Corp. – September 25, 2017) – Arctic Star Exploration Corp. (TSXV: ADD) (the “Company”) is pleased to report that it is in receipt of analytical results from its summer 2017 exploration program at it’s wholly owned CAP Property, located approximately 80 km northwest of Prince George, B.C.
The summer exploration program at CAP focused within an area measuring approximately 3 kilometres by 1 kilometres, and included four drill holes, geologic mapping and sampling, and prospecting. The program was highly successful, resulting in the discovery of an exposure of carbonatite and related rocks with greater than 90-m strike-length and an estimated thickness exceeding 50 m. To date, the discovery has been tested by only a single drill hole (see news release dated August 8, 2017).
Prospecting highlights are summarized as follows:
- The strike-length of carbonatite and related rock types encountered in outcrop and drilling totals approximately 3 kilometres;
- Five samples contained0.20{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} Nb2O3 with a peak value of 0.96{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} Nb2O3; and
- Three samples contained >0.20{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} TREO (Total Rare Earth Element Oxides) with a peak value of 0.39{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} TREO; and
- Three samples contained >5.00{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} P2O5 with a peak value of 12.62{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} P2O5.
The samples referred to above are all selected grab samples, and they are not necessarily representative of the mineralization hosted on the property.
Highlights from Drill Hole CAP17-004 are summarized as follows:
- 85.24 to 95.66 metres: 0.35{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} Nb2O5 across 10.42 metres, and including 2.26 metres of 0.63{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} Nb2O5;
- 98.87 to 118.50 metres: 19.63 metres of 9.94{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} P2O5, including 2.55 metres of 20.97{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} P2O5; and
- 136.1 to 138.5 metres: 2.4 metres of 0.81{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} TREO.
The CAP Carbonatite Complex remains an early staged discovery with potential for a wide variety of commodities. Initial surface and drill hole samples demonstrate a strong potential for niobium, rare earth element, and phosphate. Moreover, as this new carbonatite has only been tested by a single drill hole, there exists a significant potential for further discovery.
Of additional interest are some anomalous concentrations of gold encountered within carbonatite and alkaline rocks during the 2017 exploration. A peak value of 69 ppb Au was noted from a pyrrhotite-bearing, calcio-carbonatite sample at 136.1 metres depth; this interval also contained in excess of 1{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} TREO’s.
According to Jody Dahrouge, P.Geo. and President of Dahrouge Geological (consultant to Arctic Star):
“The discovery of highly anomalous concentrations of Niobium, Phosphate and REO’s at such an early stage in the exploration of the CAP project should be considered highly encouraging. Future exploration at CAP will follow up on surface samples that contained highly anomalous concentrations of Niobium and which may be related to drill hole CAP17-004.”
Mineralized carbonatite systems have been mined for and/or are potential sources for commodities such as REE’s, niobium, tantalum, copper, nickel, iron, titanium, zirconium, platinum group elements (PGEs), gold, fluorspar, lime, sodalite, and vermiculite. Strong demand growth, stemming in part from a number of green energy solutions, has placed upward price pressure on a number of those commodities associated with carbonatites.
Some of the more notable active and past producing carbonatite deposits known worldwide include Palabora (Cu, Ni, Au, PGE’s, other), South Africa; Bayon Obo (REE’s, Fe, Nb, fluorspar), China; Araxa (Nb), Brazil; Cargill (Phosphate), Canada; Niobec (Nb), Canada; Mountain Pass (REE’s), United States; and Mount Weld (REE’s), Australia.
Further details will be released as they come available.
Jody Dahrouge, B.Sc, P.Geo., Dahrouge Geological Consulting Ltd., a qualified person as defined by National Instrument 43-101, supervised the preparation of the technical information in this news release.
Quality Assurance/Quality Control
Drill holes reported in this press release were drilled using NQ-sized core. Samples were then cut into equal halves using a diamond core-saw. One half is being stored near the project, and the other half sent for analysis at Actlabs of Kamloops, BC. A systematic quality control procedure was implemented for the drill-core, where quarter core duplicates and blanks were inserted at a rate of one every twenty samples. Laboratory standards and standard laboratory quality-control procedures were relied upon for the drill-core and prospecting rock samples. Samples received at Actlabs are first crushed up to 90{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce}, passing 2 mm. Further, samples were analyzed with analytical codes 8-REE, 8-XRF (Ta, Nb) and FA-AA. The 8-REE method requires the sample to be ground to 95{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} passing -200 mesh and then treated with lithium metaborate/tetraborate fusion with subsequent analysis by ICP and ICP/MS. The 8-XRF method fuses the pulverized split sample with a lithium metaborate/tetraborate flux in platinum crucibles with the molten glass cast into a glass disc in platinum crucibles. These glass discs are analyzed by XRF. A 30 g sub-sample of the pulverized sample was subjected to Actlabs’ 1A2 analysis (Fire Assay with AA finish).
© 2017 Canjex Publishing Ltd. All rights reserved.
ON BEHALF OF THE BOARD OF DIRECTORS OF
ARCTIC STAR EXPLORATION CORP.
“Patrick Power”
Patrick Power, President
(604) 689-1799
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Disclaimer for Forward-Looking Information
Such forward-looking statements and information are subject to risks, uncertainties and other factors which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statement. Specific risks included that we may not be able to finance our intended acquisition or intended exploration and we may not obtain regulatory approval for the transaction.
- Published in Arctic Star Exploration, Mining, News Home
Canamex Commissions An Updated Mineral Resource and New Preliminary Economic Assessment
Momentum Public Relations
Press Release: September 21, 2017
Vancouver, British Columbia / TheNewswire / September 21, 2017 – Canamex Resources Corp. (“Canamex”) (TSX-V: CSQ) (OTCBB: CNMXF) (FSE: CX6) is pleased to announce it has commissioned an Updated Mineral Resource and new Preliminary Economic Assessment on its 100{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce}-owned Bruner gold project in Nye County, Nevada.
Updated Preliminary Economic Assessment
The Company is commissioning a new Mineral Resource and updated Preliminary Economic Assessment with Welsh Hagen Associates, who completed the 2016 Preliminary Economic Assessment (“PEA”). Welsh Hagen Associates is a small engineering firm comprised of a group of seasoned mining professionals, all of whom have decades of mine-related experience in their own fields of expertise. The new resource and updated PEA will be based upon the addition of the successful drilling campaigns completed in late 2016 and mid-2017, where the majority of holes drilled intersected gold (and silver) bearing material as reported by the Company previously, and above the cut-off grades over mineable widths as referenced in the 2016 PEA announced on March 3, 2016 and amended in September 2016 Management’s expectation of the new PEA is an increase in total in-pit resources and an improvement in project economics through the processing of more gold in resource and the conversion to resources of material currently carried as internal pit waste in the PEA. See the link below for the location of the intercepts relative to the resource boundaries and final pit design presented in the PEA. (http://canamex.us/images/Penelas_pit_and_resource_boundary_with_new_drill_intercepts.pdf).
The results of the new resource and updated PEA are expected before year-end 2017, with a Technical Report to follow within 45 days.
Penelas Resource Area Update
Eight new drill holes, drilled to extensions of the gold zones between two preliminary sub-pits of the current Penelas resource area intersected gold across significant widths above the cut-off grade referenced in the Company’s PEA. The best intercept is in hole B-1708 and contains 200 feet (61 metres) from 615-815 feet (187.5-248.5 metres) of 1.224 gpt Au and 8.38 gpt Ag (1.287 gpt Au (eq)). All eight holes intersected gold mineralization above cut-off grade across tens of metres as referenced in a news release dated August 22, 2017. The eight holes drilled at the Penelas resource area cover an area of approximately 200 metres by 150 metres located mostly in the data gap between the two preliminary sub-pits as outlined in the Company’s PEA, and is an area which is carried mostly as waste in the finalized conceptual pit design presented in the PEA. Conversion of waste material to resources could add to the proposed mine life, reduce the strip ratio for the Penelas pit, and improve the economics of the project.
HRA Resource Area Update
Seven of the eight holes drilled at the northern spire located immediately north of the northern pit limit of the HRA resource area intersected gold over significant widths and above the cut-off grade used in the Company’s PEA. The best intercept at the northern spire is in hole B-1709 and is 55 feet (16.8 metres) grading 3.022 gpt Au and 124.5 gpt Ag (4.676 gpt Au (eq)) between 420-475 feet (128-144.8 metres). Several of the holes intersected 1-3 gpt Au material in the first twenty feet of the holes, reflecting near-surface mineralization. Drilling at the northern spire covered an area of approximately 120 metres squared. It is expected these recently completed drill holes will expand the current resource at the HRA resource area.
The true thickness of the 2017 intercepts is currently undetermined, pending a thorough review of the geology and the relationship between lithologies, structure, and the intercepts reported herein, which is currently underway.
Paymaster Resource Area
The 2016 PEA carries the Paymaster resource area entirely in the inferred category. The Company drilled 23 new holes into the Paymaster resource area in late 2016 as recommended in the PEA to significantly increase the drill data density to allow re-estimation of the resource and to be able to upgrade the resource from inferred to indicated status. Success in this endeavor would allow for these resources to be included in a follow-on feasibility study, subject to the conclusions and recommendations in the updated PEA.
Greg Hahn, President and COO and a Certified Professional Geologist (#7122) is the Qualified Person under NI43-101 responsible for preparing and reviewing the data contained in this press release.
ON BEHALF OF THE BOARD
Gregory A Hahn, President and COO
Contact: (720) 244-2022
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
CAUTIONARY NOTE TO US INVESTORS REGARDING RESOURCE ESTIMATION
Canamex Resources prepares its resource estimates in accordance with standards of the Canadian Institute of Mining, Metallurgy and Petroleum referred to in Canadian National Instrument 43-101 (NI 43-101). These standards are different from the standards generally permitted in reports filed with the SEC. Under NI 43-101, Canamex Resources reports measured, indicated and inferred resources, measurements, which are generally not permitted in filings made with the SEC. The estimation of measured resources and indicated resources involve greater uncertainty as to their existence and economic feasibility than the estimation of proven and probable reserves. U.S. investors are cautioned not to assume that any part of measured or indicated resources will ever be converted into economically mineable reserves. The estimation of inferred resources involves far greater uncertainty as to their existence and economic viability than the estimation of other categories of resources.
CAUTION CONCERNING FORWARD-LOOKING STATEMENTS
This news release includes certain forward-looking statements or information. All statements other than statements of historical fact included in this release are forward-looking statements that involve various risks and uncertainties. Forward-looking statements in this news release include statements in relation to the timing, cost and other aspects of the planned programs on the Bruner property; the potential for development of the mineral resources; the potential mineralization and geological merits of the Bruner property; and other future plans, objectives or expectations of the Company. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s plans or expectations include the risk that actual results of current and planned exploration activities, including the results of the Company’s future drilling program(s) on the Bruner property, will not be consistent with the Company’s expectations; the geology, grade and continuity of any mineral deposits and the risk of unexpected variations in mineral resources, grade and/or recovery rates; fluctuating metals prices; possibility of accidents, equipment breakdowns and delays during exploration; exploration cost overruns or unanticipated costs and expenses; uncertainties involved in the interpretation of drilling results and geological tests; availability of capital and financing required to continue the Company’s future exploration programs and preparation of geological reports and studies; delays in the preparation of geological reports and studies; the metallurgical characteristics of mineralization contained within the Bruner property are yet to be fully determined; general economic, market or business conditions; competition and loss of key employees; regulatory changes and restrictions including in relation to required permits for exploration activities (including drilling permits) and environmental liability; timeliness of government or regulatory approvals; and other risks detailed herein and from time to time in the filings made by the Company with securities regulators. In connection with the forward-looking information contained in this news release, the Company has made numerous assumptions, including that the Company’s future programs will proceed as planned and within budget. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as otherwise required by applicable securities legislation.
Copyright (c) 2017 TheNewswire – All rights reserved.
- Published in Canamex Resources Corp., Mining, News Home
Intema launches all-new Canvas(TM) feature integrated in email marketing platform eFlyerMaker
Momentum Public Relations
Press Release: September 21, 2017
MONTREAL, QUEBEC–(Marketwired – Sept. 21, 2017) – Intema Solutions Inc. (“Intema” or the “Corporation“) (TSX VENTURE:ITM) launched Canvas™, a graphic editing tool fully integrated within eFlyerMaker and unveiled a revised version of eFlyerMaker, bringing it up to the highest standards of evolving needs of email marketers.
Canvas™ is a built-in graphic editing tool packed with many features to fully customize user’s newsletters. It is the most advanced user-friendly and professional like design tool available right within the email software. With Canvas™ eFlyerMaker users can be more productive and more intuitive than ever and can launch a campaign directly from Canvas™. Customers have expressed the needs to create content both written and visual without ever having to exit eFlyerMaker.
This new graphic editing tool comes with a selection of 140 fonts, the largest selection available in email marketing software on the market and three different editor modes; Drag&Drop, Classic WYSIWYG, and basic HTML.
The revision of eFlyerMaker brings more features to build email content faster, easier and more responsive. It does have a number of features previously absent and brings the software up to unreached standards by competing applications.
A new segmentation tool was added; behavioral segmentation allows marketers to be even more select on who received the emails sent through the app. It allows segments to be based on certain pre-defined activities by the subscribers automatically. Adding this segmentation tool to the already integrated Artificial Intelligence MatcherAnalytics predictive functionality offers marketers the most advanced and modern marketing application for relevant and engaging communication with subscribers.
The revision of eFlyerMaker and the integration of Canvas™ “reaffirms our commitment to the online marketing community and it is also a guarantee that we remain on the lookout for the new needs of customers” said Sebastien Plourde CTO.
Intema intends to launch an intensive “Inbound” marketing campaign to increase the number of users and paying customers. The company focuses on financing marketing through private placement and revenues generated by medium and larger size accounts.
About INTEMA SOLUTIONS Inc.
INTEMA’s mission is to integrate technologies to marketing. The company develops technologies for marketing and services related to predictive marketing, relationship marketing and database marketing. Since its inception, INTEMA has dedicated its efforts to deliver key solutions to the marketing industry.
For more information, please visit our corporate website at intema.com and our product websites eflyermaker.com and matcheranalytics.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined on policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Roger Plourde
CEO, Intema Solutions, Inc.
(514) 861-1881
roger.ploude@intema.ca
www.intema.ca
- Published in Intema Solutions, News Home, Technology
- 1
- 2